Drug Repurposing for Unmet Medical Needs; Request for Information; Extension of Comment Pe
The Food and Drug Administration (FDA, the Agency, or we) is extending the comment period for the notice entitled "Drug Repurposing for Unmet Medical Needs; Request for Information" that appeared in the Federal Register of May 12, 2026 (91 FR 25897). In the notice, FDA requested comments to solicit input on FDA's effor
| Agency | Health and Human Services Department, Food and Drug Administration |
|---|---|
| Document type | Notice |
| Published | 2026-06-11 |
| Summary | The Food and Drug Administration (FDA, the Agency, or we) is extending the comment period for the notice entitled "Drug Repurposing for Unmet Medical Needs; Request for Information" that appeared in the Federal Register of May 12, 2026 (91 FR 25897). In the notice, FDA requested comments to solicit input on FDA's efforts with respect to drug repurposing to address unmet medical needs. The Agency is taking this action to allow interested persons additional time to submit comments. |
| Document number | 2026-11691 |
| Official record | https://www.federalregister.gov/documents/2026/06/11/2026-11691/drug-repurposing-for-unmet-medical-needs-request-for-information-extension-of-comment-period |